Ads
related to: triple negative breast cancer survival rates
Search results
Scientists create tailored drug for aggressive breast cancer
Medical Xpress· 6 days agoThe discovery is particular to triple negative breast cancer, which makes up 15% of all diagnosed ...
CNN anchor Sara Sidner to undergo double mastectomy amid breast cancer battle
theGrio via AOL· 5 days agoThey also...
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
Digital Journal· 4 days ago83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian ...
29 Celebrities Who Have Had Breast Cancer
SheKnows via Yahoo News· 7 days agoFrom A-list celebrities to the people in our own lives, breast cancer can can truly happen to anyone — and the stats show it. After skin cancer ...
Latest American Cancer Society study places emphasis on cancer disparities among Black women
WREG articles via Yahoo News· 1 day agoMEMPHIS, Tenn. — According to the American Cancer Society, research shows black women have the...
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
KTLA-TV Los Angeles· 4 days agoShanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced ...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 4 days agoWith its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts. A ...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 5 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 4 days agoOf the 37 patients evaluable for efficacy assessment, the objective response rate (ORR) and disease...
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term...
Digital Journal· 4 days agoPoster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer ...